117 related articles for article (PubMed ID: 20429600)
1. Quantum mechanical/molecular mechanical molecular dynamics simulation of wild-type and seven mutants of CpNagJ in complex with PUGNAc.
Lameira J; Alves CN; Moliner V; Martí S; Castillo R; Tuñón I
J Phys Chem B; 2010 May; 114(20):7029-36. PubMed ID: 20429600
[TBL] [Abstract][Full Text] [Related]
2. Enzyme molecular mechanism as a starting point to design new inhibitors: a theoretical study of O-GlcNAcase.
Lameira J; Alves CN; Tuñón I; Martí S; Moliner V
J Phys Chem B; 2011 May; 115(20):6764-75. PubMed ID: 21542586
[TBL] [Abstract][Full Text] [Related]
3. Computational analysis of human OGA structure in complex with PUGNAc and NAG-thiazoline derivatives.
de Alencar NA; Sousa PR; Silva JR; Lameira J; Alves CN; Martí S; Moliner V
J Chem Inf Model; 2012 Oct; 52(10):2775-83. PubMed ID: 22937904
[TBL] [Abstract][Full Text] [Related]
4. Protein-ligand interaction study of CpOGA in complex with GlcNAcstatin.
Sousa PR; de Alencar NA; Lima AH; Lameira J; Alves CN
Chem Biol Drug Des; 2013 Feb; 81(2):284-90. PubMed ID: 23066949
[TBL] [Abstract][Full Text] [Related]
5. A quantum mechanics/molecular mechanics study of the protein-ligand interaction of two potent inhibitors of human O-GlcNAcase: PUGNAc and NAG-thiazoline.
Lameira J; Alves CN; Moliner V; Martí S; Kanaan N; Tuñón I
J Phys Chem B; 2008 Nov; 112(45):14260-6. PubMed ID: 18939790
[TBL] [Abstract][Full Text] [Related]
6. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
[TBL] [Abstract][Full Text] [Related]
7. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
[TBL] [Abstract][Full Text] [Related]
8. A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase.
Stubbs KA; Zhang N; Vocadlo DJ
Org Biomol Chem; 2006 Mar; 4(5):839-45. PubMed ID: 16493467
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor.
Shanmugasundaram B; Debowski AW; Dennis RJ; Davies GJ; Vocadlo DJ; Vasella A
Chem Commun (Camb); 2006 Nov; (42):4372-4. PubMed ID: 17057847
[TBL] [Abstract][Full Text] [Related]
10. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
[TBL] [Abstract][Full Text] [Related]
11. Active-pocket size differentiating insectile from bacterial chitinolytic β-N-acetyl-D-hexosaminidases.
Liu T; Zhang H; Liu F; Chen L; Shen X; Yang Q
Biochem J; 2011 Sep; 438(3):467-74. PubMed ID: 21692744
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
Rao FV; Dorfmueller HC; Villa F; Allwood M; Eggleston IM; van Aalten DM
EMBO J; 2006 Apr; 25(7):1569-78. PubMed ID: 16541109
[TBL] [Abstract][Full Text] [Related]
13. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
Gao Y; Parker GJ; Hart GW
Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
Lee JE; Park JH; Moon PG; Baek MC
Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
[TBL] [Abstract][Full Text] [Related]
15. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
Kim EJ; Perreira M; Thomas CJ; Hanover JA
J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
[TBL] [Abstract][Full Text] [Related]
16. The synthesis and biological evaluation of some carbocyclic analogues of PUGNAc.
Scaffidi A; Stubbs KA; Vocadlo DJ; Stick RV
Carbohydr Res; 2008 Nov; 343(16):2744-53. PubMed ID: 18804755
[TBL] [Abstract][Full Text] [Related]
17. Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase.
Archontis G; Simonson T; Karplus M
J Mol Biol; 2001 Feb; 306(2):307-27. PubMed ID: 11237602
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
[TBL] [Abstract][Full Text] [Related]
19. Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants.
Cetinbaş N; Macauley MS; Stubbs KA; Drapala R; Vocadlo DJ
Biochemistry; 2006 Mar; 45(11):3835-44. PubMed ID: 16533067
[TBL] [Abstract][Full Text] [Related]
20. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
Arias EB; Cartee GD
Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
